Share this Virus Delays Stir Deadline Concerns in Generic Drug Patent Cases Bloomberg Law March 23, 2020 "New coronavirus-related disruptions to federal courts are causing attorneys’ concerns about meeting tight deadlines unique to generic drug patent disputes." Read the article
"New coronavirus-related disruptions to federal courts are causing attorneys’ concerns about meeting tight deadlines unique to generic drug patent disputes." Read the article